Apoptosis-resistant e1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions

Biotechnology and Bioengineering

Volumn 63, Issue 5, 1999, Pages 529-543

  Mercille, Sylvain ^a   Massie, Bernard ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Apoptosis; E1B 19K; Hybridoma; Monoclonal antibodies; Myeloma; Perfusion

Indexed keywords

BIOTECHNOLOGY; MONOCLONAL ANTIBODIES;

APOPTOSIS; PERFUSION CELL CULTURE;

CELL CULTURE;

CHIMERIC ANTIBODY; PROTEIN E1B 19K; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE PHASE; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CULTURE MEDIUM; GROWTH RATE; MYELOMA CELL; OXYGEN CONSUMPTION; PROTEIN EXPRESSION;

ADENOVIRUS E1B PROTEINS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CLONE CELLS; HUMANS; MULTIPLE MYELOMA; OXYGEN; PERFUSION; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033526532     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19990605)63:5<529::AID-BIT3>3.0.CO;2-X     Document Type: Article

References (104)

1. Al-Rubeai M, Emery AN. 1990. Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. J Biotechnol 16:67-85.
2. Al-Rubeai M, Emery AN, Chalder S, Jan DC. 1992. Specific monoclonal antibody productivity and the cell-cycle comparisons of batch, continuous and perfusion cultures. Cytotechnology 9:85-98.
3. Aunins JG, Woodson BA Jr, Hale TK, Wang DIC. 1989. Effects of paddle impeller geometry on power input and mass transfer in small-scale animal cell culture vessels. Biotechnol Bioeng 34:1127-1132.
4. Avgerinos GC, Drapeau D, Socolow JS, Mao JI, Hsiao K, Broeze RJ. 1990. Spin filter perfusion system for high density culture: Production of recombinant urinary type plasminogen activator in CHO cells. Bio/Technology 8:54-58.
5. Banik GG, Heath CA. 1994. An investigation of cell density effects on hybridoma metabolism in a homogeneous perfusion reactor. Bioprocess Eng 11:229-237.
6. Banik GG, Heath CA. 1995. Hybridoma growth and antibody production as a function of cell density and specific growth rate in perfusion culture. Biotechnol Bioeng 48:289-300.
7. Barbiero G, Duranti F, Bonelli G, Amenta JS, Baccino FM. 1995. Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp Cell Res 217:410-418.
8. Batt BC, Davis RH, Kompala DS. 1990. Inclined sedimentation for selective retention of viable hybridomas in a continuous suspension bioreactor. Biotechnol Prog 6:458-464.
9. Bebbington CR, Renner G, Thomson D, King D, Abrams D, Yarranton GT. 1992. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology 10:169-175.
10. Behrendt U, Koch S, Gooch DD, Steegmans U, Comer MJ. 1994. Mass spectrometry: A tool for on-line monitoring of animal cell cultures. Cytotechnology 14:157-165.
11. Boraston R, Thompson PW, Garland S, Birch JR. 1984. Growth and oxygen requirements of antibody producing mouse hybridoma cells in suspension culture. Dev Biol Stand 55:101-111.
12. Borth N, Heider R, Assadian A, Katinger H. 1992. Growth and production kinetics of human x mouse and mouse hybridoma cells at reduced temperature and serum content. J Biotechnol 25:319-331.
13. Byars N, Kidson C. 1970. Programmed synthesis and export of immunoglobulin by synchronized myeloma cells. Nature 226:648-650.
14. Cazzador L, Mariani L. 1993. Growth and production modeling in hybridoma continuous cultures. Biotechnol Bioeng 42:1322-1330.
15. Chen P, Tian J, Kovesdi I, Bruder JT. 1998. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J Biol Chem 273:5815-5820.
16. Cherlet M, Kromenaker SJ, Srienc F. 1995. Surface IgG content of murine hybridomas: Direct evidence for variation of antibody secretion rates during the cell cycle. Biotechnol Bioeng 47:535-540.
17. Clem RJ, Miller LK. 1994. Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14:5212-5222.
18. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. 1997. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20.
19. de la Broise D, Noiseux M, Lemieux R, Massie B. 1991. Long-term perfusion culture of hybridoma: A "grow or die" cell cycle system. Biotechnol Bioeng 38:781-787.
20. de la Broise D, Noiseux M, Massie B, Lemieux R. 1992. Hybridoma perfusion systems: A comparison study. Biotechnol Bioeng 40:25-32.
21. de Tremblay M, Perrier M, Chavarie C, Archambault J. 1993. Optimization of fed-batch culture of hybridoma cells using dynamic programming: Single and multi-feed cases. Bioprocess Eng 7:229-234.
22. Doverskog M, Ljunggren J, Ohman L, Haggstrom L. 1997. Physiology of cultured animal cells. J Biotechnol 59:103-115.
23. Duke RC, Cohen JJ. 1992. Morphological and biochemical assays of apoptosis. p. 3.17.1-3.17.16. In: Janssen K, ed. Current protocols in immunology. New York: Wiley.
24. Fassnacht D, Rossing S, Franek F, Al-Rubeai M, R Pörtner. 1998. Effect of Bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media. Cytotechnology 26:219-225.
25. Fitzpatrick L, Jenkins HA, Butler M. 1993. Glucose and glutamine metabolism of a murine B-lymphocyte hybridoma grown in batch culture. Appl Biochem Biotechnol 43:93-116.
26. Fong W, Zhang Y, Yung P. 1997. Optimization of monoclonal antibody production: Combined effects of potassium acetate and perfusion in a stirred tank bioreactor. Cytotechnology 24:47-54.
27. Franek F, Dolnikova J. 1991. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: Effect of nutrient concentration. Cytotechnology 7:33-38.
28. Fussenegger M, Mazur X, Bailey JE. 1997. A novel cytostatic process enhances the productivity of chinese hamster ovary cells. Biotechnol Bioeng 55:927-939.
29. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE. 1998. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16: 468-472.
30. Garatun-Tjeldsto O, Pryme IF, Weltman JK, Dowben RM. 1976. Synthesis and secretion of light-chain immunoglobulin in two successive cycles of synchronized plasmacytoma cells. J Cell Biol 68:232-239.
31. Gamier A, Voyer R, Tom R, Perret S, Jardin B, Kamen AA. 1996. Dissolved carbon dioxide accumulation in a large scale and high density production of TGFβ receptor with baculovirus infected Sf-9 cells. Cytotechnology 22:53-63.
32. Gervais C, Paquette D, Burns-Tardif A, Martin L, Massie B. 1998. Development of high output expression vectors for antibody production in mammalian cells. In: Nagai K, Wachi M, eds. Animal Cell Technology: Basic and Applied Aspects. Proceedings of the JAACT Meeting. Dordrecht, Netherlands: Vol. 9, p 349-354.
33. Goochee CF, Monica T. 1990. Environmental effects on protein glycosylation. Bio/Technology 8:421-427.
34. Gossen M, Bonin AL, Freundlieb S, Bujard H. 1994. Inducible gene expression systems for higher eukaryotic cells. Curr Opin Biotechnol 5:516-520.
35. Hansen HA, Damgaard B, Emborg C. 1993. Enhanced antibody production associated with altered amino acid metabolism in a hybridoma high-density perfusion culture established by gravity separation. Cytotechnology 11:155-166.
36. Hershberger PA, LaCount DJ, Friesen PD. 1994. The apoptotic suppressor p35 is required early during baculovirus replication and is targeted to the cytosol of infected cells. J Virol 68:3467-3477.
37. Hiller Gw, Clark DS, Blanch HW. 1993. Cell retention-chemostat studies of hybridoma cells: Analysis of hybridoma growth and metabolism in continuous suspension culture on serum-free medium. Biotechnol Bioeng 42:185-195.
38. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z. 1994. Flow cytometric detection of apoptosis: Comparison of the assays in situ DNA degradation and chromatin changes. Cytometry 15:237-244.
39. Hu W-S, Meier J, Wang DC. 1986. Use of surface aerator to improve oxygen transfer in cell culture. Biotechnol Bioeng 28:122-125.
40. Hu W-S, Oberg MG. 1990. Monitoring and control of animal cell bioreactors: Biochemical engineering considerations. In: Lubiniecki AS, ed. Large Scale mammalian cell technology. New York: Marcel Dekker. p 451-481.
41. Jayme DW. 1991. Nutrient optimization for high density biological production applications. Cytotechnology 5:15-30.
42. Johnson M, Andre G, Chavarie C, Archambault J. 1990. Oxygen transfer rates in a mammalian cell culture bioreactor equipped with a cell-lift impeller. Biotechnol Bioeng 35:43-49.
43. Johnson M, Lanthier S, Massie B, Lefebvre G, Kamen AA. 1996. Use of Centritech Lab Centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Progress 12:855-864.
44. Kamen AA, Bedard C, Tom R, Perret S, Jardin B. 1996. On-line monitoring of respiration in recombinant-baculovirus infected and uninfected insect cell bioreactor cultures. Biotechnol Bioeng 50:36-48.
45. Kamen AA, Gamier A, André G, Archambault J, Chavarie C. 1995. Determination of mass transfer parameters in surface aerated bioreactors with bubble entrainment. Chem Eng J 59:187-193.
46. Karl DW, Donovan M, Flickinger MC. 1990. A novel acid proteinase released by hybridoma cells. Cytotechnology 3:157-166.
47. Kitano K, Shintani Y, Ichimori Y, Tsukamoto K, Sasi S, Kida M. 1986. Production of human monoclonal antibodies by heterohybridomas. Appl Microbiol Biotechnol 24:282-286.
48. Kromenaker SJ, Srienc F. 1991. Cell cycle-dependent protein accumulation by producer and non-producer murine hybridoma cell lines: A population analysis. Biotechnol Bioeng 38:665-677.
49. Kyung YS, Peshwa MV, Gryte DM, Hu WS. 1994. High density culture of mammalian cells with dynamic perfusion based on on-line oxygen uptake rate measurements. Cytotechnology 14:183-190.
50. Linardos TI, Kalogerakis N, Behie LA. 1992. Cell cycle model for growth rate and death rate in continuous suspension hybridoma cultures. Biotechnol Bioeng 40:359-368.
51. Linek V, Vacek V, Benes P. 1987. A critical review and experimental verification of the correct use of the dynamic method for determination of oxygen transfer in aerated agitated vessel to water electrolyte solutions and viscous liquids. Chem Eng J 34:11-34.
52. Maiorella BL, Dorin G, Carion A, Harano D. 1991. Crossflow microfiltration of animal cells. Biotechnol Bioeng 37:121-126.
53. Maiorella BL, Winkelhake J, Young J, Moyer B, Bauer R, Hora M, Andya J, Thomson J, Pate T, Parekh R. 1993. Effect of culture conditions on IgM antibody structure, pharmacokinetics, and activity. Bio/Technology 11:387-392.
54. Martinou I, Fernandez PA, Missotten M, White E, Allet B, Sadoul R, Martinou JC. 1995. Viral proteins E1B-19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol 128:201-208.
55. Mastrangelo AJ, Betenbaugh MJ. 1998. Overcoming apoptosis: new methods for improving protein expression systems. Trends Biotechnol 16: 88-95.
56. Matthews CC, Feldman EL. 1996. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hypertonic induced programmed cell death. J Cell Physiol 166:323-331.
57. Mercille S, Massie B. 1994a. Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng 44: 1140-1154.
58. Mercille S, Massie B. 1994b. Induction of apoptosis in oxygen-deprived cultures of hybridoma cells. Cytotechnology 15:117-128.
59. Mercille S, Johnson M, Bourget L, Lemieux R, Massie B. 1994a. Process development and kinetic analysis of a protein-free hybridoma perfusion system. In: Spier RE, Griffiths JB, Berthold W, eds. Animal cell technology, products of today, prospects for tomorrow. Oxford, England: Butterworth-Heinemann. p 532-538.
60. Mercille S, Johnson M, Lanthier S, Bourget L, Massie B. 1994b. Kinetic analysis of the "grow or die" cell cycle system in perfusion culture of hybridomas. Abstracts of the 44th Canadian Chemical Engineering Conference, Calgary, Alberta, Canada, October 3-7.
61. Mercille S, Johnson M, Lemieux R, Massie B. 1994c. Filtration-based perfusion of hybridoma cultures in protein-free medium: Reduction of membrane fouling by medium supplementation with DNaseI. Biotechnol Bioeng 43:833-846.
62. Mercille S, Massie B. 1998. Apoptosis-resistant NS/0-E1B-19K myeloma cells exhibit increased viability and chB43 monoclonal antibody productivity under cell cycle modulating conditions. Cytotechnology 28: 189-203.
63. Mercille S, Jolicoeur P, Gervais C, Paquette D, Mosser DD, Massie B. 1999. Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene. Biotechnol Bioeng 63:516-528.
64. Miller LK. 1997. Baculovirus interaction with host apoptotic pathways. J Cell Physiol 173:178-182.
65. Mohan SB, Chohan SR, Eade J, Lyddiatt A. 1993. Molecular integrity of monoclonal antibodies produced by hybridoma cells in batch culture and in continuous-flow culture with integrated product recovery. Biotechnol Bioeng 42:974-986.
66. Mosser DD, Massie B. 1994. Genetically engineering mammalian cell lines for increased viability and productivity. Biotechnol Adv 12:253-277.
67. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. 1997. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17:5317-5327.
68. Oh SKW, Chua FKF, Choo ABH. 1995. Intracellular responses of productive hybridomas subjected to high osmotic pressure. Biotechnol Bioeng 46:525-535.
69. Øyaas K, Ellingsen TE, Dyrset N, Levine DW. 1994a. Hyperosmotic hybridoma cell cultures: Increased monoclonal antibody production with addition of glycine betaine. Biotechnol Bioeng 44:991-998.
70. Øyaas K, Ellingsen TE, Dyrset N, Levine DW. 1994b. Utilization of osmoprotective compounds by hybridoma cells exposed to hyperosmotic stress. Biotechnol Bioeng 43:77-89.
71. Papoutsakis ET. 1998. Express together and conquer. Nat Biotechnol 16: 416-417.
72. Park SH, Ryu DY. 1994. Cell cycle kinetics and monoclonal antibody productivity of hybridoma cells during perfusion culture. Biotechnol Bioeng 44:361-367.
73. Paulovich AG, Toczyski DP, Hartwell LH. 1997. When checkpoints fail. Cell 88:315-321.
74. Perreault J, Lemieux R. 1993. Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology 13:99-105.
75. Prior CP, Doyle KR, Duffy SA, Hope JA, Moellering BJ, Prior GM, Scott RW, Tolbert WR. 1989. The recovery of highly purified biopharmaceuticals from perfusion cell culture bioreactors. J Parent Sci Tech 43:15-23.
76. Ramirez OT, Mutharasan R. 1990. Cell cycle and growth-phase dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures. Biotechnol Bioeng 36:839-848.
77. Reddy S, Miller WM. 1994. Effects of abrupt and gradual osmotic stress on antibody production and content in hybridoma cells that differ in production kinetics. Biotechnol Prog 10:165-173.
78. Reuveny S, Velez D, Macmillan JD, Miller L. 1986. Comparison of cell propagation methods for their effect on monoclonal antibody yield in fermenters. J Immunol Methods 86:53-59.
79. Richieri RA, Williams LS, Chau PC. 1991. Cell cycle dependancy of monoclonal antibody production in asynchronous serum-free hybridoma cultures. Cytotechnology 5:243-254.
80. Robinson DK, Seamans TC, Gould SL, Distephano DJ, Chan CP, Lee DJ, Bibila TA, Glazomitsky K, Munshi S, Daughtery B, O'Neill Palladino L, Stafford-Hollis J, Hollis GF, Silberklang M. 1994. Optimization of a fed-batch process for production of a recombinant antibody. Ann NY Acad Sci 745:285-296.
81. Robinson DK, Memmert KW. 1991. Kinetics of recombinant immunglobulin production by mammalian cells in continuous culture. Biotechnol Bioeng 38:972-976.
82. Schläpfer BS, Scheibler M, Holtorf A-P, Nguyen HV, Pluschke G. 1995. Development of optimized transfectoma cell lines for production of chimeric antibodies in hollow fiber cell culture systems. Biotechnol Bioeng 45:310-319.
83. Schmid G, Wilke CR, Blanch HW. 1992. Continuous hybridoma suspension cultures with and without cell retention: kinetics of growth, metabolism and product formation. J Biotechnol 22:31-40.
84. Shi Y, Ryu DDY, Park SH. 1993. Monoclonal antibody productivity and the metabolic pattern of perfusion cultures under varying oxygen tensions. Biotechnol Bioeng 42:430-439.
85. Simpson NH, Milner AE, Al-Rubeai M. 1997. Prevention of hybridoma cell death by Bcl-2 during sub-optimal culture conditions. Biotechnol Bioeng 54:1-16.
86. Simpson NH, Singh RP, Perani A, Goldenzon C, Al-Rubeai M. 1998. In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the Bcl-2 gene. Biotechnol Bioeng 59:90-98.
87. Singh RP, Al-Rubeai M, Gregory CD, Emery AN. 1994a. Cell death by necrosis and apoptosis during the culture of commercially important cell lines. In: Spier RE, Griffith JB, Berthold W, eds. Animal Cell Technology: Products of Today, prospects for Tomorrow. Oxford, England: Butterworth-Heinemann. p 187-191.
88. Singh RP, Al-Rubeai M, Gregory CD, Emery AN. 1994b. Cell death in bioreactors: A role for apoptosis. Biotechnol Bioeng 44:720-726.
89. Singh RP, Emery AN, Al-Rubeai M. 1996. Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene Bcl-2. Biotechnol Bioeng 52:166-175.
90. Singleton JR, Dixit VM, Feldman EL. 1996. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 271:31791-31794.
91. Sokolova IA, Volgin AU, Makarova NV, Volgina VV, Shishkin SS, Khodarev NN. 1992. Internucleasomal chromatin degradation in myeloma and B-hybridoma cell cultures. FEBS Lett 313:295-299.
92. Spier RE, Griffith JB. 1983. An examination of the data and concepts germane to the oxygenation of cultured animal cells. Dev Biol Standard 55:81-92.
93. Strasser A, Anderson RL. 1995. Bcl-2 and thermotolerance cooperate in cell survival. Cell Growth Differentiation 6:799-805.
94. Suzuki E, Ollis DF. 1989. Cell cycle model for antibody production kinetics. Biotechnol Bioeng 34:1398-1402.
95. Suzuki E, Ollis DF. 1990. Enhanced antibody production at slow growth rates: Experimental demonstration and a simple structured model. Biotechnol Prog 6:231-236.
96. Suzuki E, Terada S, Ueda H, Fujita T, Komatsu T, Takayama S, Reed J. 1997. Establishing apoptosis resistant cell lines for improving protein productivity of cell culture. Cytotechnology 23:55-59.
97. Takahachi K, Terada S, Ueda H, Makishima F, Suzuki E. 1994. Growth rate suppression of cultures mammalian cells enhances protein productivity. Cytotechnology 12:1-8.
98. Telford WG, King LE, Fraker PJ. 1992. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13:137-143.
99. Terada S, Fukuoka K, Fujita T, Komatsu T, Takayama S, Reed JC, Suzuki E. 1997a. Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology 25:17-23.
100. Terada S, Itoh Y, Ueda H, Suzuki E. 1997b. Characterization and fed-batch culture of hybridoma overexpressing apoptosis suppressing gene Bcl-2. Cytotechnology 24:135-141.
101. Tokashiki H, Takamatsu H. 1993. Perfusion culture apparatus for suspended mammalian cells. Cytotechnology 13:149-159.
102. Trampler F, Sonderhoff SA, Pui PWS, Kilburn D, Piret JM. 1994. Acoustic cell filter for high density perfusion culture of hybridoma cells. Bio/Technology 12:281-284.
103. Van Erp R, Adorf M, van Sommeren AP, Schonherr OT, Gribnau TC. 1991. Monitoring of the production of monoclonal antibodies by hybridomas. Part 1: Long-term cultivation in hollow fibre bioreactors using serum-free medium. J Biotechnol 20:235-248.
104. Watanabe S, Yagi Y, Pressman D. 1973. Immunoglobulin production in synchronized cultures of human hematopoietic cell lines: Variation of synthetic and secretion activities during the cell cycle. J Immunology 111:797-804.